Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Long-Term Growth Rate is Expected for the Implantable Neurostimulation Devices Market Between 2025 and 2034?
The market scope for implantable neurostimulation devices has seen an accelerated expansion in the past few years. With the worth expected to climb from $8.68 billion in 2024 to $9.64 billion in 2025, the compound annual growth rate (CAGR) stands at 11.1%. The drivers of growth in the historic period are traced back to a surge in the demand for non-drug treatments and minimally invasive procedures, an increasing geriatric population, a broad spectrum of psychiatric disorders, and a rising prevalence of chronic diseases.
The market for implantable neurostimulation devices is projected to experience swift expansion over the next several years, ultimately reaching $14.53 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The predicted surge during this forecast period can be associated with factors such as a growing incidence of neurological disorders, increases in lifestyle-related diseases, heightened awareness, a surge in spinal cord injuries, and amplified healthcare spending. The forecast period is also likely to see emerging trends such as advancements in sensing technology, continuous development in neurostimulation technologies, the introduction of technologically evolved products, the incorporation of closed-loop systems, and the integration of wireless technology.
What Combination of Drivers Is Leading to Accelerated Growth in the Implantable Neurostimulation Devices Market?
The escalating incidence of neurological conditions is anticipated to spur the expansion of the implantable neurostimulation device market in the imminent future. Neurological disorders are conditions impacting the structure or operation of the nervous system, which can manifest in symptoms such as paralysis, seizures, and cognitive defects. The elevated exposure to risk elements like high blood pressure, developmental irregularities, trauma, or injury contributes to increased diagnosis rates of such disorders. Implantable neurostimulation devices are employed for treating these conditions to regulate nerve activity and mitigate symptoms when alternative treatments prove inadequate or ineffectual. For example, the Alzheimer’s Association, a non-profit health organization based in the US, estimates that around 6.9 million Americans aged 65 and above are living with Alzheimer’s disease in 2024, with 73% being 75 years old or older. This figure is forecasted to rise to 12.7 million by 2050. As such, the ascending incidence of neurological disorders will act as a catalyst for the growth of the implantable neurostimulation device market.
Explore Comprehensive Insights Into The Global Implantable Neurostimulation Devices Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp
What Are the Key Firms That Are Driving Transformation in the Implantable Neurostimulation Devices Market?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC
What Current Trends in the Implantable Neurostimulation Devices Market Should Industry Players Pay Attention To?
Leading firms in the implantable neurostimulation devices industry are making strides in creating cutting-edge products, such as spinal cord stimulation (SCS) systems, aimed at managing chronic pain. An SCS system, a type of medical device, leverages electric shocks to manipulate neural activity in the spinal cord, relieving long-term pain and improving patient lives, especially when conventional treatments fail. For example, Abbott, a US medical device firm, revealed in December 2022 that the U.S. Food and Drug Administration (FDA) had approved their Eterna spinal cord stimulation (SCS) system. The Eterna SCS stands as the smallest implantable, rechargeable device of this type on the market, designed for optimal daily comfort. It incorporates Abbott’s unique BurstDR stimulation technology, replicating the brain’s natural firing patterns for enhanced pain alleviation, and is preferred by 87% of users over the usual tingling stimulation. The Eterna system guarantees user-friendliness with its minimal recharging needs, demanding just around five annual recharges owing to its Xtend energy technology. It accommodates comprehensive body MRI scans via TotalScan technology and can adapt to future technological progress without needing replacement. Additionally, Abbott provides mobile app integration, allowing users to monitor the device’s battery life and charging status in real time on their iPhones.
Secure Your Global Implantable Neurostimulation Devices Market Report Now for Fast and Efficient Delivery!
Which Key Segments Stand Out in Understanding the Composition of the Implantable Neurostimulation Devices Market?
The implantable neurostimulation devicesmarket covered in this report is segmented –
1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies
What Regions Are Driving Expansion in the Implantable Neurostimulation Devices Market?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does the Definition of the Implantable Neurostimulation Devices Market Include?
Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body and are used to modulate nerve activity. The devices represent a sophisticated approach to managing conditions that may not respond well to medication alone, offering patients a chance to improve their quality of life.
Browse Through More Similar Reports By The Business Research Company:
Implantable Infusion Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Implantable Loop Recorders Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-loop-recorders-global-market-report
Implantable Biomaterials Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
